+44 (0) 20 7556 4465 sakram@cooley.com
Download full bio
Jazz Pharmaceuticals Acquisition of Redx Pharma's pan-RAF Inhibitor Program Valued up to $206 Million
Emerging Companies
Venture Capital
Orchard Therapeutics Closes $150 Million Series C September 27, 2018
+44 (0) 20 7556 4465 office sakram@cooley.com
Dashwood69 Old Broad StreetLondon, UK EC2M 1QS